发明名称
摘要 <p>This invention concerns arylsulfonyl pyrazoline carboxamidine derivatives as antagonists of 5-HT 6 receptors, to methods for the preparation of these compounds and to novel intermediates useful for their synthesis. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, mild cognitive impairment, sleep disorders, eating disorders, anorexia, bulimia, binge eating disorders, panic attacks, akathisia, attention deficit hyperactivity disorder, attention deficit disorder, withdrawal from abuse of cocaine, ethanol, nicotine or benzodiazepines, pain, disorders associated with spinal trauma or head injury, hydrocephalus, functional bowel disorder, Irritable Bowel Syndrome, obesity and type-2 diabetes. The compounds have the general formula (1): wherein the symbols have the meanings given in the description.</p>
申请公布号 JP2011517443(A) 申请公布日期 2011.06.09
申请号 JP20110500192 申请日期 2009.03.17
申请人 发明人
分类号 C07D231/06;A61K31/415;A61K31/4155;A61K31/416;A61K31/4162;A61K31/438;A61P1/04;A61P1/14;A61P3/04;A61P3/10;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P25/34;A61P25/36;C07D231/54;C07D231/56;C07D403/12;C07D471/10;C07D491/107 主分类号 C07D231/06
代理机构 代理人
主权项
地址